While the Company continues to explore a number of mutually beneficial alternatives with the Bank, among others, the Company will continue to limit its aggregate borrowings to the financing of its basic working capital needs, primarily including certain inventories, accounts receivable, plant and equipment and similar "borrowing base" needs. As these amounts are not expected to exceed $25 million during the term of the Loan, the Loan Amendment has also reduced certain fees associated with the Company's un-utilized excess borrowing capacities and reduced such reserved capacities to $25 million, from $50 million.

The Company can give no assurances that the risk factors disclosed in the Company's most recent Form 10-K, Form 10-Q and other securities filings with the U.S. Securities and Exchange Commission, including changing business, regulatory or economic conditions, might not cause the Company to violate one or more covenants which could result in any default or acceleration of any obligations under the Loan Amendment or any other agreements, or adversely impact the Company's efforts to obtain such consent from the Bank and to reinstate such dividends in the future, or otherwise impact the Company's ongoing business plans, strategies or financial results.